共 465 条
[91]
Fujii H(1996)The role of free/total prostate-specific antigen ration in the prediction of final pathologic state for men with clinically localized prostate cancer Urology 48 51-54
[92]
Bruchovsky N(1997)The free to total serum prostate-specific antigen ratio for staging prostate carcinoma J Urol 157 544-547
[93]
Wilson JD(1996)Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate Urology 48 240-248
[94]
Bruchovsky N(1995)Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening JAMA 274 1214-1220
[95]
Wilson JD(1994)Serum prostate specific antigen complexed to alpha 1 chymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones J Urol 152 1510-1514
[96]
Harper ME(1998)Serum percent free PSA does not predict extraprostatic spread of prostate cancer Am J Clin Pathol 109 533-539
[97]
Pike A(1998)The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases J Urol 159 935-940
[98]
Peeling WB(1998)Transition zone volume adjusted prostate specific antigen value predicts extracapsular carcinoma of the prostate in patients with intermediate prostate specific antigen levels Eur Urol 33 32-38
[99]
Griffiths K(1998)Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension J Urol 159 1251-1259
[100]
Labrie F(1990)Carcinoma of the prostate: value of transrectal sonography to detect extension into the neurovascular bundle Am J Rad 155 1015-1019